{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:04:31Z","timestamp":1777532671094,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010446","name":"Institute for basic science","doi-asserted-by":"crossref","award":["IBS-R025-D1-2014"],"award-info":[{"award-number":["IBS-R025-D1-2014"]}],"id":[{"id":"10.13039\/501100010446","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2019R1A6A1A03033084"],"award-info":[{"award-number":["2019R1A6A1A03033084"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) pandemic is causing a global crisis. It is still unresolved. Although many therapies and vaccines are being studied, they are still in their infancy. As this pandemic continues, rapid and accurate research for the development of therapies and vaccines is needed. Therefore, it is necessary to understand characteristics of diseases caused by SARS-CoV-2 through animal models. Syrian hamsters are known to be susceptible to SARS-CoV-2. They were intranasally inoculated with SARS-CoV-2. At 2, 4, 8, 12, and 16\u00a0days post-infection (dpi), these hamsters were euthanized, and tissues were collected for ultrastructural and microstructural examinations. Microscopic lesions were prominent in the upper and lower respiratory tracts from 2 and 4 dpi groups, respectively. The respiratory epithelium in the trachea, bronchiole, and alveolar showed pathological changes. Inflammatory cells including neutrophils, lymphocytes, macrophages, and eosinophils were infiltrated in\/around tracheal lamina propria, pulmonary vessels, alveoli, and bronchiole. In pulmonary lesions, alveolar wall was thickened with infiltrated inflammatory cells, mainly neutrophils and macrophages. In the trachea, epithelial damages started from 2 dpi and recovered from 8 dpi, consistent with microscopic results, High levels of SARS-CoV-2 nucleoprotein were detected at 2 dpi and 4 dpi. In the lung, lesions were most severe at 8 dpi. Meanwhile, high levels of SARS-CoV-2 were detected at 4 dpi. Electron microscopic examinations revealed cellular changes in the trachea epithelium and alveolar epithelium such as vacuolation, sparse micro-organelle, and poor cellular margin. In the trachea epithelium, the number of cytoplasmic organelles was diminished, and small vesicles were prominent from 2 dpi. Some of these electron-lucent vesicles were filled with virion particles. From 8 dpi, the trachea epithelium started to recover. Because of shrunken nucleus and swollen cytoplasm, the N\/C ratio of type 2 pneumocyte decreased at 8 and 12 dpi. From 8 dpi, lamellar bodies on type 2 pneumocyte cytoplasm were increasingly observed. Their number then decreased from 16 dpi. However, there was no significant change in type 1 pneumocyte. Viral vesicles were only observed in the cytoplasm of type 2 pneumocyte. In conclusion, ultra- and micro-structural changes presented in this study may provide useful information for SARS-CoV-2 studies in various fields.<\/jats:p>","DOI":"10.1186\/s13567-021-00988-w","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T13:04:06Z","timestamp":1631797446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Ultra- and micro-structural changes of respiratory tracts in SARS-CoV-2 infected Syrian hamsters"],"prefix":"10.1186","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-3729","authenticated-orcid":false,"given":"Myeon-Sik","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6540-8945","authenticated-orcid":false,"given":"Byung Kwan","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1303-2808","authenticated-orcid":false,"given":"Daram","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8840-3191","authenticated-orcid":false,"given":"Eun Young","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4374-1963","authenticated-orcid":false,"given":"Yeonhwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2324-5898","authenticated-orcid":false,"given":"Kyung Won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9483-859X","authenticated-orcid":false,"given":"Chae Woong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1231-1485","authenticated-orcid":false,"given":"Gou Young","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3624-3392","authenticated-orcid":false,"given":"Sang-Myeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0392-2513","authenticated-orcid":false,"given":"Bumseok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"988_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450\u2013454","journal-title":"Nature"},{"key":"988_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631\u2013637","journal-title":"J Pathol"},{"key":"988_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0014-5793(01)03056-3","volume":"508","author":"G Yamano","year":"2001","unstructured":"Yamano G, Funahashi H, Kawanami O, Zhao L-X, Ban N, Uchida Y, Morohoshi T, Ogawa J, Shioda S, Inagaki N (2001) ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells1. FEBS Lett 508:221\u2013225","journal-title":"FEBS Lett"},{"key":"988_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271\u2013280","journal-title":"Cell"},{"key":"988_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181:281\u2013292","journal-title":"Cell"},{"key":"988_CR6","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","volume":"94","author":"Y Wan","year":"2020","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 94:e00127-e120","journal-title":"J Virol"},{"key":"988_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","volume":"586","author":"C Mu\u00f1oz-Fontela","year":"2020","unstructured":"Mu\u00f1oz-Fontela C, Dowling WE, Funnell SGP, Gsell P-S, Riveros-Balta AX, Albrecht RA, Andersen H, Baric RS, Carroll MW, Cavaleri M (2020) Animal models for COVID-19. Nature 586:509\u2013515","journal-title":"Nature"},{"key":"988_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","volume":"28","author":"S-H Sun","year":"2020","unstructured":"Sun S-H, Chen Q, Gu H-J, Yang G, Wang Y-X, Huang X-Y, Liu S-S, Zhang N-N, Li X-F, Xiong R (2020) A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe 28:124\u2013133","journal-title":"Cell Host Microbe"},{"key":"988_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.4269\/ajtmh.20-0762","volume":"103","author":"GB Moreau","year":"2020","unstructured":"Moreau GB, Burgess SL, Sturek JM, Donlan AN, Petri WA Jr, Mann BJ (2020) Evaluation of K18-hACE2 mice as a model of SARS-CoV-2 infection. Am J Trop Med Hyg 103:1215\u20131219","journal-title":"Am J Trop Med Hyg"},{"key":"988_CR10","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1128\/JVI.00737-08","volume":"82","author":"J Netland","year":"2008","unstructured":"Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82:7264\u20137275","journal-title":"J Virol"},{"key":"988_CR11","doi-asserted-by":"publisher","first-page":"15511","DOI":"10.1128\/JVI.79.24.15511-15524.2005","volume":"79","author":"AC Sims","year":"2005","unstructured":"Sims AC, Baric RS, Yount B, Burkett SE, Collins PL, Pickles RJ (2005) Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol 79:15511\u201315524","journal-title":"J Virol"},{"key":"988_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/JVI.79.1.503-511.2005","volume":"79","author":"A Roberts","year":"2005","unstructured":"Roberts A, Vogel L, Guarner J, Hayes N, Murphy B, Zaki S, Subbarao K (2005) Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol 79:503\u2013511","journal-title":"J Virol"},{"key":"988_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.virol.2008.07.026","volume":"380","author":"SR Schaecher","year":"2008","unstructured":"Schaecher SR, Stabenow J, Oberle C, Schriewer J, Buller RM, Sagartz JE, Pekosz A (2008) An immunosuppressed Syrian golden hamster model for SARS-CoV infection. Virology 380:312\u2013321","journal-title":"Virology"},{"key":"988_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41392-021-00552-0","volume":"6","author":"L Yuan","year":"2021","unstructured":"Yuan L, Zhu H, Zhou M, Ma J, Chen R, Chen Y, Chen L, Wu K, Cai M, Hong J (2021) Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster. Signal Transduct Target Ther 6:136","journal-title":"Signal Transduct Target Ther"},{"key":"988_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/v12070779","volume":"12","author":"N Osterrieder","year":"2020","unstructured":"Osterrieder N, Bertzbach LD, Dietert K, Abdelgawad A, Vladimirova D, Kunec D, Hoffmann D, Beer M, Gruber AD, Trimpert J (2020) Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters. Viruses 12:779","journal-title":"Viruses"},{"key":"988_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.7326\/M20-0533","volume":"172","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhou P, Wei Y, Yue H, Wang Y, Hu M, Zhang S, Cao T, Yang C, Li M (2020) Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19. Ann Intern Med 172:629\u2013632","journal-title":"Ann Intern Med"},{"key":"988_CR17","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1165\/rcmb.2020-0280LE","volume":"63","author":"AD Gruber","year":"2020","unstructured":"Gruber AD, Osterrieder N, Bertzbach LD, Vladimirova D, Greuel S, Ihlow J, Horst D, Trimpert J, Dietert K (2020) Standardization of reporting criteria for lung pathology in SARS-CoV-2\u2013infected hamsters: What Matters? Am J Respir Cell Mol Biol 63:856\u2013859","journal-title":"Am J Respir Cell Mol Biol"},{"key":"988_CR18","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1080\/22221751.2020.1858177","volume":"9","author":"K Rosenke","year":"2020","unstructured":"Rosenke K, Meade-White K, Letko M, Clancy C, Hansen F, Liu Y, Okumura A, Tang-Huau T-L, Li R, Saturday G (2020) Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Emerg Microbes Infect 9:2673\u20132684","journal-title":"Emerg Microbes Infect"},{"key":"988_CR19","doi-asserted-by":"publisher","first-page":"100059","DOI":"10.1016\/j.xcrm.2020.100059","volume":"1","author":"A Pizzorno","year":"2020","unstructured":"Pizzorno A, Padey B, Julien T, Trouillet-Assant S, Traversier A, Errazuriz-Cerda E, Fouret J, Dubois J, Gaymard A, Lescure F-X (2020) Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Cell Rep Med 1:100059","journal-title":"Cell Rep Med"},{"key":"988_CR20","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1038\/s41467-021-24521-x","volume":"12","author":"R Robinot","year":"2021","unstructured":"Robinot R, Hubert M, de Melo GD, Lazarini F, Bruel T, Smith N, Levallois S, Larrous F, Fernandes J, Gellenoncourt S (2021) SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance. Nat Commun 12:4354","journal-title":"Nat Commun"},{"key":"988_CR21","doi-asserted-by":"publisher","first-page":"e01683","DOI":"10.1128\/JVI.01683-20","volume":"94","author":"RL Brocato","year":"2020","unstructured":"Brocato RL, Principe LM, Kim RK, Zeng X, Williams JA, Liu Y, Li R, Smith JM, Golden JW, Gangemi D (2020) Disruption of adaptive immunity enhances disease in SARS-CoV-2-infected Syrian hamsters. J Virol 94:e01683-e1720","journal-title":"J Virol"},{"key":"988_CR22","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/s41591-020-1070-6","volume":"26","author":"LH Tostanoski","year":"2020","unstructured":"Tostanoski LH, Wegmann F, Martinot AJ, Loos C, McMahan K, Mercado NB, Yu J, Chan CN, Bondoc S, Starke CE (2020) Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat Med 26:1694\u20131700","journal-title":"Nat Med"},{"key":"988_CR23","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","volume":"583","author":"SF Sia","year":"2020","unstructured":"Sia SF, Yan L-M, Chin AWH, Fung K, Choy K-T, Wong AYL, Kaewpreedee P, Perera RAPM, Poon LLM, Nicholls JM (2020) Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 583:834\u2013838","journal-title":"Nature"},{"key":"988_CR24","doi-asserted-by":"publisher","first-page":"614256","DOI":"10.3389\/fimmu.2020.614256","volume":"11","author":"AC Fagre","year":"2020","unstructured":"Fagre AC, Manhard J, Adams R, Eckley M, Zhan S, Lewis J, Rocha SM, Woods C, Kuo K, Liao W (2020) A potent SARS-CoV-2 neutralizing human monoclonal antibody that reduces viral burden and disease severity in Syrian hamsters. Front Immunol 11:614256","journal-title":"Front Immunol"},{"key":"988_CR25","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/cid\/ciaa644","volume":"71","author":"JF-W Chan","year":"2020","unstructured":"Chan JF-W, Zhang AJ, Yuan S, Poon VK-M, Chan CC-S, Lee AC-Y, Chan W-M, Fan Z, Tsoi H-W, Wen L (2020) Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis 71:2428\u20132446","journal-title":"Clin Infect Dis"},{"key":"988_CR26","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1073\/pnas.2009799117","volume":"117","author":"M Imai","year":"2020","unstructured":"Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N, Watanabe T, Ujie M, Takahashi K, Ito M (2020) Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U S A 117:16587\u201316595","journal-title":"Proc Natl Acad Sci U S A"},{"key":"988_CR27","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.cell.2020.09.049","volume":"183","author":"J Kreye","year":"2020","unstructured":"Kreye J, Reincke SM, Kornau H-C, S\u00e1nchez-Sendin E, Corman VM, Liu H, Yuan M, Wu NC, Zhu X, Lee C-CD (2020) A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model. Cell 183:1058\u20131069","journal-title":"Cell"},{"key":"988_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.humpath.2020.07.023","volume":"105","author":"WO Vasquez-Bonilla","year":"2020","unstructured":"Vasquez-Bonilla WO, Orozco R, Argueta V, Sierra M, Zambrano LI, Mu\u00f1oz-Lara F, L\u00f3pez-Molina DS, Arteaga-Livias K, Grimes Z, Bryce C (2020) A review of the main histopathological findings in the Coronavirus Disease 2019 (COVID-19). Hum Pathol 105:74\u201383","journal-title":"Hum Pathol"},{"key":"988_CR29","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:1417\u20131418","journal-title":"Lancet"},{"key":"988_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/pathogens9100785","volume":"9","author":"AE Oxford","year":"2020","unstructured":"Oxford AE, Halla F, Robertson EB, Morrison BE (2020) Endothelial cell contributions to COVID-19. Pathogens 9:785","journal-title":"Pathogens"},{"key":"988_CR31","doi-asserted-by":"publisher","first-page":"2001634","DOI":"10.1183\/13993003.01634-2020","volume":"56","author":"A Huertas","year":"2020","unstructured":"Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F, Guignabert C, Humbert M (2020) Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J 56:2001634","journal-title":"Eur Respir J"},{"key":"988_CR32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bjd.19327","volume":"183","author":"I Colmenero","year":"2020","unstructured":"Colmenero I, Santonja C, Alonso-Ria\u00f1o M, Noguera-Morel L, Hern\u00e1ndez-Mart\u00edn A, Andina D, Wiesner T, Rodr\u00edguez-Peralto JL, Requena L, Torrelo A (2020) SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol 183:729\u2013737","journal-title":"Br J Dermatol"},{"key":"988_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/PL00007554","volume":"175","author":"L Creuwels","year":"1997","unstructured":"Creuwels L, Van Golde LMG, Haagsman HP (1997) The pulmonary surfactant system: biochemical and clinical aspects. Lung 175:1\u201339","journal-title":"Lung"},{"key":"988_CR34","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1513\/AnnalsATS.201411-507FR","volume":"12","author":"S Han","year":"2015","unstructured":"Han S, Mallampalli RK (2015) The role of surfactant in lung disease and host defense against pulmonary infections. Ann Am Thorac Soc 12:765\u2013774","journal-title":"Ann Am Thorac Soc"},{"key":"988_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.imbio.2006.12.001","volume":"212","author":"R Leth-Larsen","year":"2007","unstructured":"Leth-Larsen R, Zhong F, Chow VTK, Holmskov U, Lu J (2007) The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages. Immunobiology 212:201\u2013211","journal-title":"Immunobiology"},{"key":"988_CR36","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00408-020-00393-8","volume":"198","author":"B Kerget","year":"2020","unstructured":"Kerget B, Kerget F, Ko\u00e7ak AO, K\u0131z\u0131ltun\u00e7 A, Araz \u00d6, U\u00e7ar EY, Akg\u00fcn M (2020) Are serum interleukin 6 and surfactant protein D levels associated with the clinical course of COVID-19? Lung 198:777\u2013784","journal-title":"Lung"},{"key":"988_CR37","doi-asserted-by":"publisher","first-page":"103645","DOI":"10.1016\/j.resp.2021.103645","volume":"288","author":"F Cattel","year":"2021","unstructured":"Cattel F, Giordano S, Bertiond C, Lupia T, Corcione S, Scaldaferri M, Angelone L, De Rosa FG (2021) Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): role in SARS-CoV-2-related lung injury. Respir Physiol Neurobiol 288:103645","journal-title":"Respir Physiol Neurobiol"},{"key":"988_CR38","doi-asserted-by":"publisher","first-page":"101413","DOI":"10.1016\/j.cocis.2020.101413","volume":"51","author":"A Ghati","year":"2021","unstructured":"Ghati A, Dam P, Tasdemir D, Kati A, Sellami H, Sezgin GC, Ildiz N, Franco OL, Mandal AK, Ocsoy I (2021) Exogenous pulmonary surfactant: A review focused on adjunctive therapy for severe acute respiratory syndrome coronavirus 2 including SP-A and SP-D as added clinical marker. Curr Opin Colloid Interface Sci 51:101413","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"988_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev.immunol.24.021605.090720","volume":"24","author":"ME Rothenberg","year":"2006","unstructured":"Rothenberg ME, Hogan SP (2006) The eosinophil. Annu Rev Immunol 24:147\u2013174","journal-title":"Annu Rev Immunol"},{"key":"988_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/vim.2018.0150","volume":"32","author":"AS Flores-Torres","year":"2019","unstructured":"Flores-Torres AS, Salinas-Carmona MC, Salinas E, Rosas-Taraco AG (2019) Eosinophils and respiratory viruses. Viral Immunol 32:198\u2013207","journal-title":"Viral Immunol"},{"key":"988_CR41","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/qjmed\/hcaa137","volume":"113","author":"G Lippi","year":"2020","unstructured":"Lippi G, Henry BM (2020) Eosinophil count in severe coronavirus disease 2019. QJM 113:511\u2013512","journal-title":"QJM"},{"key":"988_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/qjmed\/hcaa138","volume":"113","author":"GQ Qian","year":"2020","unstructured":"Qian GQ, Zhang X, Ma AHY, Yang NB (2020) Response to: Eosinophil count in severe coronavirus disease 2019. QJM 113:513\u2013514","journal-title":"QJM"},{"key":"988_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2010.01.055","volume":"126","author":"D Simon","year":"2010","unstructured":"Simon D, Wardlaw A, Rothenberg ME (2010) Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol 126:3\u201313","journal-title":"J Allergy Clin Immunol"}],"container-title":["Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-021-00988-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13567-021-00988-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-021-00988-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T15:11:15Z","timestamp":1675696275000},"score":1,"resource":{"primary":{"URL":"https:\/\/veterinaryresearch.biomedcentral.com\/articles\/10.1186\/s13567-021-00988-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1186\/s13567-021-00988-w","relation":{},"ISSN":["1297-9716"],"issn-type":[{"value":"1297-9716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"1 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}